Cell-free method for the quantitative measurement of virus neutralizing antibodies

Didier Trono, Priscilla Turelli
2022
Brevet

Résumé

The invention provides an in vitro method for the cell-free quantification of virus neutralizing activity, such as the SARS-CoV-2 neutralizing activity, of biological samples and kit for carrying out the method. The invention also provides a method of screening biological samples or collections of molecules to identify neutralizing antibodies or antiviral drugs.

Source officielle

https://infoscience.epfl.ch/record/294369?ln=fr

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Cell-free method for the quantitative measurement of virus neutralizing antibodies

Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection

A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies

A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies

Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection